Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
322 participants
OBSERVATIONAL
2017-03-21
2020-02-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Delayed Cognitive Impairment in Cardiac Arrest Survivors With Good Neurological Outcomes
NCT05830422
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
NCT06387225
Brain Heart InterActioNs in Cardiac Arrest. Ancillary Study of the HEAVENwARd Trial
NCT06327334
Effect of Serial Remote Ischemic Conditioning on Dynamic Cerebral Autoregulation in Patients With Intravenous Thrombolysis (SRICDCA-IVT)
NCT05550103
The Neuroprotective Effect of Remote Ischemic Preconditioning on Ischemic Cerebral Vascular Disease
NCT01321749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Day 0: Neurological examination (First examination will be performed within 2 hours after IHCA)
* Day1 - 7: Neurological examination
* Day7, 14, 21, 28: Neurological examination, CPC score
* Day90: CPC score, survival
* Day180: CPC score, survival
* Day 360: CPC score, survival
\<Cerebral Performance Category(CPC) score\>
* CPC 1: good cerebral performance
* CPC 2: Moderate cerebral disability(available for independent activities)
* CPC 3: Severe cerebral disability(dependent on others for daily support)
* CPC 4: Coma or vegetative state
* CPC 5: Brain death or death
\<Acronyms\>
* ACDU(Alert/Confused/Drowsy/Unresponsive) score
* FOUR(Full Outline of Unresponsiveness) score
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before Period
Patients who developed in-hosptial cardiac arrest before the implementation of new legislation on life-sustaining treatments
No interventions assigned to this group
After Period
Patients who developed in-hosptial cardiac arrest after the implementation of new legislation on life-sustaining treatments
No intervention
No intervention will be needed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention will be needed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In-hospital cardiac arrest
* Cardiopulmonary Resuscitation(CPR) code activation and/or neurology consultation for IHCA
Exclusion Criteria
* Development of IHCA during transition period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sang-Beom Jeon
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sang-Beom Jeon, Master
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Center
Seoul, Songpa-gu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-1378
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.